 MIAMI, Nov. 18, 2021 GLOBE NEWSWIRE -- Veru Inc. NASDAQ: VERU, an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, today announced that it will report financial results for its fiscal 2021 fourth quarter and full year ended September 30, 2021, on Thursday, December 2, 2021, before the market opens. Verus management will host a conference call that same day at 8 a.m. ET to review the Companys performance and to answer questions. The call will also be accessible via webcast. 